ABOUT THE CONFERENCE
Genetic testing utilization management will become more of a concern for health plans as promotions of new technology and test panels increase through a constant barrage of news articles and marketing campaigns to both physicians and the general public. Unmanaged genetic testing can create unnecessary, negative downstream medical issues and increased costs. Deciding which genetic tests provide clinical validity, utility and effectiveness is the first step and proper utilization management is the next step.
At this conference you will hear the latest ideas on where health plans should focus their efforts for genetic testing in the future, as well as the latest news on CMS genetic testing reimbursement and American Association for Cancer Research cancer genetic testing.
This conference is designed for Health Plan and ACO Medical Directors, Network Management Executives, Medical Policy and Reimbursement/Contracting personnel, in addition to anyone involved in utilization management of genetic and laboratory tests.
AGENDA
View the agenda HERE
TOPICS
- Navigating Genetic Testing In an Uncertain Landscape: The Risks and Rewards
- How Laboratories Prove Clinical Validity, Utility and Effectiveness of New Genetic Tests to CMS
- Current and Future CMS Genetic Testing Reimbursement Management, Including the New PAMA Model
- Assumption: It Never Hurts to Get More Information; Disturbing Truth: Data Overload Can Scare Patients and Distract Doctors from What’s Important
- Epigenetics
- Next-Generation Sequencing Risks and Utilization Management
- Integrating Genetic Testing and Histopathology in Quality Management of Thyroid Biopsies to Guide Therapy
- Self-Referral Issues with In-Office Pathology and Drug Testing, Including Opiates
FEATURED SPEAKER
H. Gilbert Welch, MD, MPH
Professor of Medicine, Community & Family Medicine, The Dartmouth Institute, The Geisel School of Medicine at Dartmouth; Author of the books, Overdiagnosed: Making People Sick in the Pursuit of Health and Less Medicine, More Health: 7 Assumptions That Drive Too Much Medical Care
SPEAKERS
Richard M. (Mike) Barlow
Vice President, Palmetto GBA
Elaine Jeter, MD
MolDx Medical Director, Palmetto GBA
Russel Kaufman, MD
President Emeritus, The Wistar Institute; Chief Medical Consultant, Kentmere Healthcare Consulting Corporation; Hematologist/Oncologist and Cancer Geneticist; Former Dean, Duke University Medical School
Ray Sukumar, MD
President and Medical Director, Doctor’s Pathology Services; Medical Director, MIX Management International; Advisory Board, Jefferson School of Cytotechnology; Former Director of Laboratory Director, Beebe Medical Center, Lewes, DE
REGISTRATION/ TICKETS
Registration closes on May 11. Tickets will not be sold at the door.
This event is for Health Plans and ACOs ONLY. Kentmere has the right to deny admission and refund ticket purchases made by or for any organization and/or person that is not a health plan or ACO or an employee of a health plan or ACO.
No Refunds after May 11, 2015.
See "TICKETS" for registeration options.
Don't want to register online? Call us at 302-478-7600
